To receive all the news in real time from NOXXON, please contact [email protected]
Berlin, Germany, May 30, 2022, 08:00 CEST – NOXXON Pharma NV (Euronext Growth Paris: ALNOX), a biotechnology company specializing in the development of improved cancer treatments targeting the tumor microenvironment (MET), today announces the convening of the company’s annual general meeting of shareholders (the AGM) on June 29, 2022, at 2:00 p.m. CEST, at the offices of Freshfields Bruckhaus Deringer LLP, Strawinskylaan 10, 1077 XZ in Amsterdam, The Netherlands.